Skip to main navigation Skip to search Skip to main content

The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 β

  • Muhammad Saad Khilji
  • , Danielle Verstappen
  • , Tina Dahlby
  • , Michala Cecilie Burstein Prause
  • , Celina Pihl
  • , Sophie Emilie Bresson
  • , Tenna Holgersen Bryde
  • , Phillip Alexander Keller Andersen
  • , Kristian Klindt
  • , Dusan Zivkovic
  • , Marie Pierre Bousquet-Dubouch
  • , Björn Tyrberg
  • , Thomas Mandrup-Poulsen
  • , Michal Tomasz Marzec*
  • *Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

228 Downloads (Pure)

Abstract

A central and still open question regarding the pathogenesis of autoimmune diseases, such as type 1 diabetes, concerns the processes that underlie the generation of MHC-presented autoantigenic epitopes that become targets of autoimmune attack. Proteasomal degradation is a key step in processing of proteins for MHC class I presentation. Different types of proteasomes can be expressed in cells dictating the repertoire of peptides presented by the MHC class I complex. Of particular interest for type 1 diabetes is the proteasomal configuration of pancreatic β cells, as this might facilitate autoantigen presentation by β cells and thereby their T-cell mediated destruction. Here we investigated whether so-called inducible subunits of the proteasome are constitutively expressed in β cells, regulated by inflammatory signals and participate in the formation of active intermediate or immuno-proteasomes. We show that inducible proteasomal subunits are constitutively expressed in human and rodent islets and an insulin-secreting cell-line. Moreover, the β5i subunit is incorporated into active intermediate proteasomes that are bound to 19S or 11S regulatory particles. Finally, inducible subunit expression along with increase in total proteasome activities are further upregulated by low concentrations of IL-1β stimulating proinsulin biosynthesis. These findings suggest that the β cell proteasomal repertoire is more diverse than assumed previously and may be highly responsive to a local inflammatory islet environment.

Original languageEnglish
Article numbere0222432
JournalPLoS ONE
Volume15
Issue number2
Number of pages21
ISSN1932-6203
DOIs
Publication statusPublished - 2020

Funding

This study was funded by The Punjab Educational Endowment Fund https://www.peef. org.pk/ (M.S.K), the Department of Biomedical Sciences at the University of Copenhagen https:// bmi.ku.dk/ (T.D. and M.T.M.); the Augustinus Foundation https://augustinusfonden.dk/ (T.D. and M.T.M.); EFSD/JDRF/Lilly European Programme in Type 1 Diabetes http://www.europeandiabetes foundation.org/, Vissing Fonden http://www.vissing fonden.dk/, Bjarne Jensen Fonden http://www. bjarnejensensfond.dk/, Poul og Erna Sehested Hansens Fond, no website, Eva og Hans Carl Holms Mindelegat https://haldguttenberg.dk/1-april/(M.T.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are thankful to JDRF award 31-2008-416 (ECIT Islet for Basic Research program) for providing human islets for this study. The authors also acknowledge C. Wollheim and P. Maechler (University Medical Centre, Geneva, Switzerland) for providing INS-1E cell line. Soren Buus, (Department of International Health, Immunology and Microbiology, Copenhagen, Denmark) generously provided the A20 and Jurkat cells. We would like to thank Nils Billestrup for sharing and discussing his islet sequencing data that is presented in this manuscript.

Cite this